Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Amortization of Deferred Charges: 2013-2014

Historic Amortization of Deferred Charges for Neurogene (NGNE) over the last 2 years, with Dec 2014 value amounting to $320,000.

  • Neurogene's Amortization of Deferred Charges rose 954.17% to $253,000 in Q3 2020 from the same period last year, while for Sep 2020 it was $808,000, marking a year-over-year change of. This contributed to the annual value of $320,000 for FY2014, which is 2185.71% up from last year.
  • According to the latest figures from FY2014, Neurogene's Amortization of Deferred Charges is $320,000, which was up 2,185.71% from $14,000 recorded in FY2013.
  • In the past 5 years, Neurogene's Amortization of Deferred Charges ranged from a high of $320,000 in FY2014 and a low of $14,000 during FY2013.
  • Over the past 2 years, Neurogene's median Amortization of Deferred Charges value was $167,000 (recorded in 2013), while the average stood at $167,000.
  • Data for Neurogene's Amortization of Deferred Charges shows a peak YoY skyrocketed of 2,185.71% (in 2014) over the last 5 years.
  • Neurogene's Amortization of Deferred Charges (Yearly) stood at $14,000 in 2013, then surged by 2,185.71% to $320,000 in 2014.